880 related articles for article (PubMed ID: 27262400)
1. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.
Sun YB; Qu X; Caruana G; Li J
Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400
[TBL] [Abstract][Full Text] [Related]
2. TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis.
Wang S; Meng XM; Ng YY; Ma FY; Zhou S; Zhang Y; Yang C; Huang XR; Xiao J; Wang YY; Ka SM; Tang YJ; Chung AC; To KF; Nikolic-Paterson DJ; Lan HY
Oncotarget; 2016 Feb; 7(8):8809-22. PubMed ID: 26684242
[TBL] [Abstract][Full Text] [Related]
3. Origin of myofibroblasts and cellular events triggering fibrosis.
Mack M; Yanagita M
Kidney Int; 2015 Feb; 87(2):297-307. PubMed ID: 25162398
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrotic effects of synthetic TGF-β1 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial-mesenchymal transitions.
Gwon MG; An HJ; Kim JY; Kim WH; Gu H; Kim HJ; Leem J; Jung HJ; Park KK
FASEB J; 2020 Jan; 34(1):333-349. PubMed ID: 31914629
[TBL] [Abstract][Full Text] [Related]
5. Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts.
Barnes JL; Glass Ii WF
Contrib Nephrol; 2011; 169():73-93. PubMed ID: 21252512
[TBL] [Abstract][Full Text] [Related]
6. Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis.
Lovisa S; Zeisberg M; Kalluri R
Trends Endocrinol Metab; 2016 Oct; 27(10):681-695. PubMed ID: 27372267
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
8. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells.
Rodrigues-Diez R; Lavoz C; Carvajal G; Rayego-Mateos S; Rodrigues Diez RR; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
Nephron Exp Nephrol; 2012; 122(1-2):62-74. PubMed ID: 23548835
[TBL] [Abstract][Full Text] [Related]
9. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.
He J; Xu Y; Koya D; Kanasaki K
Clin Exp Nephrol; 2013 Aug; 17(4):488-97. PubMed ID: 23430391
[TBL] [Abstract][Full Text] [Related]
10. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
[TBL] [Abstract][Full Text] [Related]
11. Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins.
Phua YL; Martel N; Pennisi DJ; Little MH; Wilkinson L
J Pathol; 2013 Apr; 229(5):685-96. PubMed ID: 23224993
[TBL] [Abstract][Full Text] [Related]
12. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
13. The origin of interstitial myofibroblasts in chronic kidney disease.
Grgic I; Duffield JS; Humphreys BD
Pediatr Nephrol; 2012 Feb; 27(2):183-93. PubMed ID: 21311912
[TBL] [Abstract][Full Text] [Related]
14. Origin and function of myofibroblasts in kidney fibrosis.
LeBleu VS; Taduri G; O'Connell J; Teng Y; Cooke VG; Woda C; Sugimoto H; Kalluri R
Nat Med; 2013 Aug; 19(8):1047-53. PubMed ID: 23817022
[TBL] [Abstract][Full Text] [Related]
15. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.
Piera-Velazquez S; Li Z; Jimenez SA
Am J Pathol; 2011 Sep; 179(3):1074-80. PubMed ID: 21763673
[TBL] [Abstract][Full Text] [Related]
17. Pericytes in kidney fibrosis.
Ren S; Duffield JS
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):471-80. PubMed ID: 23722183
[TBL] [Abstract][Full Text] [Related]
18. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.
Zeisberg EM; Potenta SE; Sugimoto H; Zeisberg M; Kalluri R
J Am Soc Nephrol; 2008 Dec; 19(12):2282-7. PubMed ID: 18987304
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
20. Diverse origins of the myofibroblast—implications for kidney fibrosis.
Falke LL; Gholizadeh S; Goldschmeding R; Kok RJ; Nguyen TQ
Nat Rev Nephrol; 2015 Apr; 11(4):233-44. PubMed ID: 25584804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
